• About us
• Contact

Advertisement

Product › Details

Erelzi

	Status	2017-01-01 sales start
	Organisation	Novartis AG (NYSE: NVS)
	Group	Novartis (Group)

Record changed: 2023-07-10

Advertisement

More documents for analgesic / antirheumatic

• [1] Paion AG. (12/22/23). "Press Release: Sale of the Business Operations". Aachen....
• [2] AlgoTherapeutix SAS. (3/14/23). "Press Release: AlgoTx Raises €20M to Conduct ATX01’s Phase 2 Program in Peripheral Neuropathic Pain". Suresnes....
• [3] Noema Pharma AG. (3/7/23). "Press Release: Noema Pharma Raises CHF 103 million (USD 112 million) in Series B Financing Round Led by Forbion and Jeito Capital". Basel....
• [4] Confo Therapeutics N.V.. (3/2/23). "Press Release: Confo Therapeutics Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554". Ghent....
• [5] AlgoTherapeutix SAS. (9/1/22). "Press Release: AlgoTx Announces Initiation of Global Phase 2 Clinical Trial of ATX01 for the Relief of Pain in Chemotherapy-induced Peripheral Neuropathy in Adults". Suresnes....
• [6] Evotec SE. (3/21/22). "Press Release: Evotec Receives €3m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme". Hamburg....
• [7] Grünenthal GmbH. (4/12/21). "Press Release: Grünenthal Acquires Mestex AG and Its Phase-III-ready Investigational Medicine MTX-071 for the Treatment of Pain Associated with Osteoarthritis of the Knee". Aachen....
• [8] Eliem Therapeutics, Inc.. (3/25/21). "Press Release: Eliem Therapeutics Emerges from Stealth with $80 Million Invested to Progress Multiple Clinical Stage Assets Targeting Neuronal Excitability Disorders". Seattle, WA & Cambrigde....
• [9] AlgoTherapeutix SAS. (11/24/20). "Press Release: AlgoTherapeutix Raises €12M to Take ATX01 into Clinical Development in Chemotherapy-induced Peripheral Neuropathy". Paris....
• [10] Bruker Corporation. (8/24/20). "Press Release: Bruker and Purity-IQ Sign Partnership Agreement to Transform the Cannabis Regulatory Landscape". Billerica, MA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.